- Amyotrophic Lateral Sclerosis
-
影響因子:
2.369
-
I S S N:
1748-2968
-
出 版 社:
Taylor & Francis
-
出 版 地:
London
-
出版國(guó)家:
England
-
刊 期:
季刊
-
創(chuàng)刊時(shí)間:
2006
-
語 種:
英文
-
審稿周期:
較慢,6-12周
-
中科院分區(qū):
3
-
投稿命中率:
較易
-
國(guó)外數(shù)據(jù)庫收錄:
IM
-
中國(guó)收錄文章數(shù):
-
5年影響因子:
2.925
-
研究領(lǐng)域:
醫(yī)學(xué)
-
官方鏈接:
http://informahealthcare.com/loi/aml
-
投稿須知:
http://informahealthcare.com/loi/aml
期刊介紹:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is an exciting new initiative. It represents a timely expansion of the journal Amyotrophic Lateral Sclerosis in response to the clinical, imaging pathological and genetic overlap between ALS and frontotemporal dementia. The expanded journal provides outstanding coverage of research in a wide range of issues related to motor neuron diseases, especially ALS (Lou Gehrig’s disease) and cognitive decline associated with frontotemporal degeneration. The journal also covers related disorders of the neuroaxis when relevant to these core conditions. The Editorial Board comprises key opinion leaders in ALS and FTD. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration aims to disseminate information on new developments in the pathogenesis and management of ALS and FTD, and enhance awareness of these devastating and often under-recognised disorders.